Federated Hermes, Inc. Ab Cellera Biologics Inc. Transaction History

Federated Hermes, Inc.

$50.2 Billion
Q2 2025

A detailed history of Federated Hermes, Inc. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 53,000 shares of ABCL stock, worth $226,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,000

Previous 947,751 94.41%

Holding current value

$226,309

Previous $2.11 Million 91.43%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$1.93 - $3.8 $1.73 Million - $3.4 Million	-894,751 Reduced 94.41%	53,000 $181,000
Q1 2025 May 08, 2025	BUY	$2.2 - $3.53 $69,330 - $111,244	31,514 Added 3.44%	947,751 $2.11 Million
Q4 2024 Feb 13, 2025	SELL	$2.48 - $3.15 $3.39 Million - $4.3 Million	-1,366,459 Reduced 59.86%	916,237 $2.68 Million
Q3 2024 Nov 13, 2024	SELL	$2.39 - $3.49 $1.06 Million - $1.55 Million	-443,320 Reduced 16.26%	2,282,696 $5.91 Million
Q2 2024 Aug 08, 2024	SELL	$2.73 - $4.73 $244,179 - $423,065	-89,443 Reduced 3.18%	2,726,016 $8.07 Million
Q1 2024 May 14, 2024	SELL	$4.29 - $5.97 $1.3 Million - $1.8 Million	-302,221 Reduced 9.69%	2,815,459 $12.8 Million
Q4 2023 Jan 31, 2024	SELL	$3.91 - $5.93 $534,391 - $810,470	-136,673 Reduced 4.2%	3,117,680 $17.8 Million
Q3 2023 Nov 13, 2023	SELL	$4.6 - $7.95 $550,629 - $951,630	-119,702 Reduced 3.55%	3,254,353 $15 Million
Q2 2023 Aug 14, 2023	BUY	$5.66 - $7.59 $2.66 Million - $3.57 Million	469,796 Added 16.18%	3,374,055 $21.8 Million
Q1 2023 May 08, 2023	BUY	$7.31 - $11.18 $2.79 Million - $4.27 Million	381,937 Added 15.14%	2,904,259 $21.9 Million
Q4 2022 Feb 13, 2023	BUY	$9.48 - $14.52 $3.97 Million - $6.07 Million	418,281 Added 19.88%	2,522,322 $25.6 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $3.38 Million - $5.03 Million	367,822 Added 21.19%	2,104,041 $20.8 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $2.56 Million - $4.77 Million	448,219 Added 34.8%	1,736,219 $18.5 Million
Q1 2022 May 13, 2022	BUY	$7.46 - $14.14 $3.43 Million - $6.51 Million	460,153 Added 55.58%	1,288,000 $12.6 Million
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $3.09 Million - $4.22 Million	237,847 Added 40.31%	827,847 $11.8 Million
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $2.88 Million - $4.14 Million	194,000 Added 48.99%	590,000 $11.8 Million
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $6.99 Million - $11.8 Million	346,000 Added 692.0%	396,000 $8.71 Million
Q4 2020 Feb 12, 2021	BUY	$39.0 - $58.9 $1.95 Million - $2.95 Million	50,000 New	50,000 $2.01 Million

Others Institutions Holding ABCL

# of Institutions

148

Shares Held

114M

Call Options Held

488K

Put Options Held

476K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $1.22B
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Ab Cellera Biologics Inc. Transaction History